30893-58-4

Basic information

• Product Name: 2-(4-(ethoxycarbonyl)phenoxy)acetic acid
• Synonyms: 2-(4-(ethoxycarbonyl)phenoxy)acetic acid
• CAS NO: 30893-58-4
• Molecular Weight: 224.213
• Mol File: 30893-58-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(4-(ethoxycarbonyl)phenoxy)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-(ethoxycarbonyl)phenoxy)acetic acid(30893-58-4)
• EPA Substance Registry System: 2-(4-(ethoxycarbonyl)phenoxy)acetic acid(30893-58-4)

Safety Data

• Hazardous Substances Data: 30893-58-4(Hazardous Substances Data)

Upstream product

• 120-47-8 Ethyl 4-hydroxybenzoate 
• 3926-62-3 sodium monochloroacetic acid 
• 1286895-60-0 4-(2-tert-butoxy-2-oxoethyl)benzoic acid ethyl ester 
• 29936-92-3 ethyl 4-(ethoxycarbonyl)phenoxyacetate 
• 35285-68-8 sodium salt of ethyl-4-hydroxybenzoate 
• 79-11-8 chloroacetic acid 

Downstream Products

• 25389-23-5 ethyl 4-(2-hydroxyethoxy)benzoate 
• 944447-01-2 ethyl 3-{2-[(2-{[(4-carboxyphenoxy)acetyl]amino}ethyl)amino]-2-oxoethoxy}benzoate 
• 944447-00-1 C₁₈H₂₆N₂O₆ 
• 7062-75-1 2-(4-Aethoxycarbonyl-phenoxy)-peressigsaeure-tert.-butylester 
• 170799-52-7 diethyl N-<4-<2-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)ethoxy>benzoyl>-L-glutamate 
• 170799-60-7 ethyl 4-<2-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)ethoxy>benzoate 
• 149325-67-7 4-<2-(2,4-diamino-6,7-dihydro-5H-cyclopentapyrimidin-5-yl)ethoxy>benzoic acid 
• 170799-65-2 ethyl 4-<2-(2-cyano-3-methoxy-2-cyclopentenyl)ethoxy>benzoate 
• 1027062-64-1 4-(2-Methanesulfonyloxy-ethoxy)-benzoic acid ethyl ester 
• 41386-38-3 4-(2-Bromo-ethoxy)-benzoic acid ethyl ester 
• 56703-36-7 4-(2-Iodoethoxy)-benzoic acid ethyl ester 

Relevant articles and documents

PYRROLIDINE DERIVATIVE OR SALT THEREOF

[PROBLEMS] To provide a compound which can be used for the treatment of a disease associated with a calcium-sensing receptor (CaSR), particularly hyperparathyroidism. [MEANS FOR SOLVING PROBLEMS] It is found that a novel pyrrolidine derivative having an aminomethyl group substituted by an arylaklyl group or the like or a salt thereof has an excellent CaSR agonistic modulation effect and also has an excellent selectivity in the inhibition of CYP2D6 which may cause a drug-drug interaction. Thus, the novel pyrrolidine derivative is useful as a therapeutic agent for a disease associated with CaSR (e.g., hyperparathyroidism, renal osteodystrophy and hypercalcemia).

PEPTIDE DERIVATIVES

The invention concerns pharmaceutically useful trifluoromethyl ketone substituted di-, tri-and tetra-peptide derivatives of the formulae Ia, Ib, Ic set out hereinafter, and salts thereof, which are inhibitors of human leukocyte elastase. Also described herein are pharmaceutical compositions containing a peptide derivative and processes and intermediates for use in the manufacture of the peptide derivatives.